Intravenous contrast medium-induced nephrotoxicity: Is the medical risk really as great as we have come to believe?

Radiology

Volumn 256, Issue 1, 2010, Pages 21-28

  Katzberg, Richard W ^a   Newhouse, Jeffrey H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEATH; DRUG SAFETY; HEART CATHETERIZATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT;

CLINICAL TRIALS AS TOPIC; CONTRAST MEDIA; CREATININE; DIAGNOSTIC IMAGING; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; OSMOLAR CONCENTRATION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953938050     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10092000     Document Type: Review

References (43)

1. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report - Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9(8):1602-1613.
2. Elicker BM, Cypel YS, Weinreb JC. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR Am J Roentgenol 2006;186(6):1651-1658.
3. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006;239(2):392-397.
4. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008;191(2):376-382.
5. Katzberg RW, Barrett BJ. Risk of iodinated contrast materia-induced nephropathy with intravenous administration. Radiology 2007;243(3):622-628.
6. Agarwal R. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications. Am J Nephrol 2007;27(1): 92-100. (Pubitemid 46364546)
7. Jacobi D, Lavigne C, Halimi JM, et al. Variability in creatinine excretion in adult diabetic, overweight men and women: consequences on creatinine-based classification of renal disease. Diabetes Res Clin Pract 2008;80(1):102-107.
8. James GD, Sealey JE, Alderman M, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects: race, sex, and age differences. Am J Hypertens 1988;1(2):124-131.
9. Toffaletti JG, McDonnell EH. Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function. Clin Chim Acta 2008;395(1-2):115-119.
10. Stone GW, Katholi RE, Katzberg RW, Solomon R, Tumlin JA. Contrast-induced nephropathy: pathophysiology and strategies for prevention. In: Key opinion leaders [CD-ROM]. Lambertville, NJ : Center for Advanced Medical Education, 2004.
11. Pedersen MM, Christiansen JS, Pedersen EB, Mogensen CE. Determinants of intraindividual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control. Clin Sci(Lond) 1992;83(4):445-451.
12. Cramer BC, Parfrey PS, Hutchinson TA, et al. Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 1985; 145(1):87-89.
13. Heller CA, Knapp J, Halliday J, O'Connell D, Heller RF. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991;155(5):329-332.
14. Langner S, Stumpe S, Kirsch M, Petrik M, Hosten N. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. AJNR Am J Neuroradiol 2008;29(8):1525-1529.
15. Oleinik A, Romero JM, Schwab K, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 2009;40(7):2393-2397.
16. Bansal GJ, Darby M. Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: a case-control study. J Comput Assist Tomogr 2009;33(3):455-459.
17. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast induced nephrotoxicity. AJR Am J Roentgenol 2009;192(3):711-718.
18. Tremblay LN, Tien H, Hamilton P, et al. Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. J Trauma 2005;59(5):1162-1166; discussion 1166-1167.
19. Rahimi A, Edmonson RP, Jones NF. Effect of radiocontrast media on kidneys of patients with renal disease. Br Med J(Clin Res Ed) 1981;282(6271):1194-1195.
20. Sagy M, Aladjem M, Shem-Tov A, et al. The renal effects of radiocontrast administration during cardioangiography in two different groups with congenital heart disease. Eur J Pediatr 1984;141(4):236-239. (Pubitemid 14193910)
21. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104(4):501-504.
22. Byrd L, Sherman RL. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine(Baltimore) 1979;58(3):270-279. (Pubitemid 9185650)
23. Harkonen S, Kjellstrand C. Contrast nephropathy. Am J Nephrol 1981;1(2):69-77.
24. Campbell DR, Flemming BK, Mason WF, Jackson SA, Hirsch DJ, MacDonald KJ. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J 1990;41(3):133-137. (Pubitemid 20202597)
25. Khoury GA, Hopper JC, Varghese Z, et al. Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography. Br J Radiol 1983;56(669):631-635. (Pubitemid 13045446)
26. Gomes AS, Baker JD, Martin-Paredero V, et al. Acute renal dysfunction after major arteriography. AJR Am J Roentgenol 1985;145(6):1249-1253. (Pubitemid 16202634)
27. Albert SG, Shapiro MJ, Brown WW, et al. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol 1994;29(6):618-623.
28. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angio graphy. Am J Med 1990;89(5):615-620. (Pubitemid 20384319)
29. Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992;182(3):649-655.
30. Mudge GH. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int 1980;18(5):540-552.
31. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343(3):180-184. (Pubitemid 30489215)
32. Becker CR, Reiser MF. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 2005;40(10):672-675.
33. Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006;41(11):815-821.
34. Thomsen HS, Morcos SK, Erley CM, et al. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008;43(3):170-178.
35. Kuhn MJ, Chen N, Sahani DV, et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure. AJR Am J Roentgenol 2008;191(1):151-157. (Pubitemid 351955220)
36. Nguyen SA, Suranyi P, Ravenel JG, et al. Isoosmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 2008;248(1):97-105.
37. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 2008;3(5):1274-1281.
38. Rudnick MR, Goldfarb S, Wexler L, et al; for the Iohexol Cooperative Study. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995;47(1):254-261.
39. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insuffi ciency. J Am Coll Cardiol 2000;36(5):1542-1548.
40. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996;275(19):1489-1494. (Pubitemid 26140761)
41. Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 2008;3(1):263-272.
42. Solomon RJ, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 2009;4(7):1162-1169.
43. Anderson RJ, Linas SL, Berns AS, et al. Nonoliguric acute renal failure. N Engl J Med 1977;296(20):1134-1138.